History Repeating Itself: The FDA’s Response to a Dangerous New Trend

Casey Marson Nov 5, 2018 4 min read
For at least the last decade (as long as I can remember growing up), the health risks of tobacco and smoking cigarettes were obvious.  The movement to raise awareness about the dangers of smoking was well underway, as television commercials, printed advertisements, and teachers were educating young people about nicotine’s […]

The CVS-Aetna Merger: Potential Gain & Loss for Consumers in Light of Growing Consolidation

Peter Luck Oct 26, 2018 4 min read
Earlier this month, the Justice Department approved a $69 billion merger between retail pharmacy company, CVS Health, and managed care company, Aetna. The approval of the merger was conditioned on an agreement that Aetna would sell its private Medicare drug plans. This merger was approved in the wake of a similar […]

The Bleeding Edge and the Unsettling Truth About Medical Devices Today

Courtney Thomas Oct 25, 2018 4 min read
After its premiere on Netflix, the documentary, The Bleeding Edge,immediately received attention for its critical look inside the billion-dollar medical device industry in the United States. In the documentary, men and women across the country openly discussed how their lives were affected after they used FDA approved medical devices. Most […]

Telemedicine: Making Health Care a Reality for All

Lisa Sendrow Oct 12, 2018 4 min read
The American Telemedical Association, a leading telehealth association, describes telemedicine as the remote delivery of health care services and clinical information using telecommunications technology including through the internet and cellphones. Telemedicine has seen an exponential increase in the last few years with about 200 telemedicine networks and 3,500 service sites […]

Developments in Drug Pricing and Anti-Kickback Laws

Matthew Thomas Oct 11, 2018 4 min read
On Wednesday, President Trump signed the Patient Right to Know Drug Prices Act. The bill tackles a number of issues that stand in the way of lowering high drug prices, particularly the discussion over the ‘gag rule’ in interactions between insurers and pharmacists. Under the current provisions of the gag […]